Table 2.
Sulfonylureas (%) | 0 |
Biguanides (%) | 67 |
Alpha-GIs (%) | 11 |
Glinides (%) | 22 |
TZDs (%) | 0 |
DPP4 inhibitors (%) | 33 |
GLP1 receptor agonists (%) | 0 |
ARBs (%) | 33 |
Calcium channel blockers (%) | 22 |
Statins (%) | 33 |
Ezetimib (%) | 11 |
Antiplatelet agents (%) | 11 |
ARBs angiotensin receptor blockers, DPP4 dipeptidyl peptidase-4, GIs glycosidase inhibitors, GLP1 glucagon-like peptide-1, TZDs thiazolidinediones